17 alpha-hydroxyprogesterone caproate has been researched along with Fibroid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bokhman, IaV; Tkeshelashvili, VT; Vishnevskiĭ, AS | 1 |
| Akobdzhanian, MA; Lipets, VIa | 1 |
2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Fibroid
| Article | Year |
|---|---|
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms | 1984 |
[Structural characteristics of the pathologically changed uterus after treatment with sex hormones].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endometriosis; Endometrium; Female; Humans; Hydroxyprogesterones; Leiomyoma; Middle Aged; Testosterone; Uterine Neoplasms | 1985 |